Makerere University
With data from the Ministry of Health revealing that a heartbreaking 80 percent of children born with Sickle Cell Disease (SCD) in Uganda die before their fifth birthday, health experts and policymakers are demanding a fundamental shift in how the nation tackles this public health emergency.
While early detection remains a critical pillar, stakeholders at the 5th Annual Uganda Sickle Cell Convention made it clear that survival depends on bringing specialized medical care directly to the communities that need it most.
Speaking at the convention, Dr. Susan Nabadda, the Commissioner for National Health Laboratory and Diagnostic Services, reaffirmed the government’s commitment to scaling up early detection, which is critical to saving lives.
We shall continue supporting the fight against this disease because our partners have supported the laboratory sector to make sure that this is possible, Dr. Nabadda said, adding that the ministry can now support diagnoses down to the community level.
Dr. Nabadda emphasized that sustained advocacy, technical expertise, and financial backing from international and multi-sectoral partners are driving the country’s current response. She noted, however, that defeating the disease requires looking beyond the medical scope.
Multi-sectoral engagement beyond the Ministry of Health is critical to expanding access, strengthening laboratory capacity, and ensuring every Ugandan receives timely, accurate sickle cell diagnosis and care, she noted.
Bringing Lifesaving Care Closer to Home
To move the needle from basic infant survival to long-term thriving, the top priority on the national agenda is the aggressive decentralization of specialized sickle cell care down to Health Centre III levels.
Currently, many families in high-burden regions such as Busoga, Acholi, and Teso must travel long, expensive distances to regional referral hospitals just to get a basic checkup or refill essential prescriptions. By pushing these services down to local health centres, the government and its partners aim to integrate two game-changing interventions into routine public healthcare:
-
Routine Genotype Screening: Identifying the disease or trait early right at the community level.
-
Universal Access to Hydroxyurea: Ensuring this life-saving drug which significantly reduces painful sickle cell crises and organ damage is consistently available and affordable for everyday Ugandans.
Changing Hearts and Minds: Overcoming Stigma
Medical interventions alone, however, cannot win this fight. Experts at the convention emphasized that clinical care must walk hand-in-hand with culture-led advocacy.
Families affected by sickle cell disease across Uganda still face stubborn, deeply entrenched social stigma. In many communities, the genetic condition is wrongfully blamed on witchcraft or family curses, leading to isolation, broken marriages, and delayed medical care. Dismantling these myths through local cultural institutions and targeted community education is deemed just as vital as dispensing medication.
Power in Partnerships: Grassroots Action
Showing how this decentralized, community-first approach works in practice, local organizations are already stepping up to fill the gaps.
In a recent collaborative effort, Direct Aid Uganda partnered with Raising Hope International Friends to bring mass screening and awareness directly into the community. Testing over 1,250 people at various Direct Aid centres, the initiative identified more than 200 individuals living with sickle cell disease.
Finding over 220 positive cases in a single targeted screening drive underscores just how heavy this burden is at the grassroots level. It proves that when you bring testing directly to the people, you uncover the hidden numbers, break the silence, and can immediately connect vulnerable families to the care they desperately need, noted Dr. Makumbi Hamuza.
By combining high-level policy changes like stocking Hydroxyurea at local health centres with aggressive grassroots partnerships and anti-stigma campaigns, health advocates hope to finally rewrite the narrative for the 20,000 to 25,000 babies born with sickle cell disease in Uganda every year.